{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:56:25Z","timestamp":1777928185003,"version":"3.51.4"},"reference-count":17,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["OMICS: A Journal of Integrative Biology"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>As COVID-19 continues to evolve around the world, there are unmet needs for rapid discovery, repurposing, and development of antiviral drugs. COVID-19 drug development is relevant for acute\/pandemic context as well as the endemic disease with SARS-CoV-2 going forward. In the present study, the transcriptome data of the SARS-CoV-2-infected human lung cell lines were used to identify the signature genes for COVID-19 infection. A set of 14 genes was considered as gene signatures from the SARS-CoV-2-infected human bronchial epithelial cells and human alveolar epithelial cell lines. With a translational bioinformatics approach based on reversal of differentially expressed gene signatures, we found that four Food and Drug Administration-approved drugs offer potential for repurposing in a context of COVID-19: Mitomycin, 4-Guanidino-Benzoic Acid, Etretinate, and Staurosporine. We suggest that these drugs warrant further consideration for possible repurposing for the treatment of COVID-19. In summary, the present study underlines the ways in which an omics approach can be harnessed toward translational bioinformatics and rapid COVID-19 drug repurposing.<\/jats:p>","DOI":"10.1089\/omi.2022.0157","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T16:40:25Z","timestamp":1677602425000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["An Omics Strategy for Translational Bioinformatics and Rapid COVID-19 Drug Repurposing"],"prefix":"10.1177","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0036-6582","authenticated-orcid":false,"given":"Amjesh","family":"Revikumar","sequence":"first","affiliation":[{"name":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University), Mangalore, Karnataka, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.235"},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","unstructured":"Blanco-Melo D Nilsson-Payant BE Liu W-C et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro ex vivo and in vivo systems. bioRxiv 2020;2020.03.24.004655; doi: 10.1101\/2020.03.24.004655","DOI":"10.1101\/2020.03.24.004655"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128"},{"key":"e_1_3_4_5_1","author":"Cong Y","year":"2022","unstructured":"Cong Y, , Endo T. Multi-omics and artificial intelligence-guided drug repositioning: Prospects, challenges, and lessons learned from COVID-19. OMICS, 2022;26(7):361\u2013371. doi: 10.1089\/omi.2022.0068","journal-title":"OMICS"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1143"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.81"},{"key":"e_1_3_4_8_1","volume":"152","author":"Donahue M","unstructured":"Donahue M, , Rose K, , Hochstrasser D, et al. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am Heart J, 152(3):478\u2013485; doi: 10.1016\/j.ahj.2006.03.007","journal-title":"Am Heart J"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.207"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2486-6"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2012.07.014"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa971"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2199"},{"issue":"4","key":"e_1_3_4_14_1","first-page":"894","article-title":"Elevated properdin and enhanced complement activation in first-degree relatives of south asian subjects with type 2 diabetes","volume":"35","author":"Somani R","year":"2012","unstructured":"Somani R, , Richardson VR, , Standeven KF, et al. Elevated properdin and enhanced complement activation in first-degree relatives of south asian subjects with type 2 diabetes. Am Diabetes Assoc, 2012; 35(4):894\u2013899; doi: 10.2337\/dc11-1483","journal-title":"Am Diabetes Assoc"},{"key":"e_1_3_4_15_1","author":"Tomasz M.","year":"1995","unstructured":"Tomasz M. Mitomycin C: Small, fast and deadly (but very selective). Chem Biol, 1995;2(9):575\u2013579.","journal-title":"Chem Biol"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00352-16"}],"container-title":["OMICS: A Journal of Integrative Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/omi.2022.0157","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/omi.2022.0157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/omi.2022.0157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:06:01Z","timestamp":1777676761000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/omi.2022.0157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1089\/omi.2022.0157"],"URL":"https:\/\/doi.org\/10.1089\/omi.2022.0157","relation":{},"ISSN":["1536-2310","1557-8100"],"issn-type":[{"value":"1536-2310","type":"print"},{"value":"1557-8100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}